Belgium Health Review
SEE OTHER BRANDS

Informing on health and wellness news in Belgium

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Belgium Health Review.

Deaf Model Antonella Ghonda Celebrates Accessibility Breakthrough at New York Fashion Week

Deaf Model Antonella Ghonda Celebrates Accessibility Breakthrough at New York Fashion Week

Belgian-born model walks NYFW with ASL interpreter, signaling progress in fashion industry inclusivity. MD, UNITED STATES, June 30, 2025 /⁨EINPresswire.com⁩/ -- Deaf model Antonella Ghonda broke new ground at this season’s New York Fashion Week...

AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound

AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound

CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85th Annual Meeting this week in Chicago for its novel...

IUI Appoints Dominic DeBiaso to Board of Directors

IUI Appoints Dominic DeBiaso to Board of Directors

WASHINGTON, DC, UNITED STATES, June 30, 2025 /⁨EINPresswire.com⁩/ -- Information Unlimited, Inc. (IUI) is proud to announce the appointment of Dominic DeBiaso to its Board of Directors. Mr. DeBiaso brings a distinguished career in data science. He...

Kaneka Eurogentec completes commercial mRNA GMP facility expansion.

Kaneka Eurogentec completes commercial mRNA GMP facility expansion.

Newly accredited GMP facility for commercial manufacturing of mRNA in anticipation of customer BLA submission SERAING, BELGIUM, June 30, 2025 /⁨EINPresswire.com⁩/ -- Kaneka Eurogentec completes commercial mRNA GMP facility expansion Newly...

3D Systems Advances Regenerative Medical Solutions for First-of-its-Kind Peripheral Nerve Repair

3D Systems Advances Regenerative Medical Solutions for First-of-its-Kind Peripheral Nerve Repair

Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage 3D Systems’ bioprinting system enabled production of a 3D-printed bioabsorbable medical...

Pharma Grade Calcium Sulphate Global Market Report 2025: Forecasts Strong Growth With Key Trends And Drivers

Pharma Grade Calcium Sulphate Global Market Report 2025: Forecasts Strong Growth With Key Trends And Drivers

The Business Research Company’s Pharma Grade Calcium Sulphate Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /⁨EINPresswire.com⁩/ -- The Business Research...

Telix Precision Medicine Announces AlFluor Radiochemistry Platform

Telix Precision Medicine Announces AlFluor Radiochemistry Platform

MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces it has launched a novel PET1 radiochemistry solution based on 18F-aluminium...

PharmStars Announces Spring 2025 Graduates: 12 Digital Health Startups Complete PharmStars’ Pharma-focused Accelerator

PharmStars Announces Spring 2025 Graduates: 12 Digital Health Startups Complete PharmStars’ Pharma-focused Accelerator

12 startups with digital innovations in rare disease complete PharmStars' 10-week PharmaU educational and mentoring accelerator program BOSTON, MA, UNITED STATES, June 17, 2025 /⁨EINPresswire.com⁩/ -- PharmStars, the pharma-focused accelerator for...

F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim

F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim

MANCHESTER, United Kingdom, June 18, 2025 (GLOBE NEWSWIRE) -- F2G Ltd, a clinical-stage biopharmaceutical company developing olorofim, a novel therapy to treat life-threatening rare fungal infections with high unmet medical need, today announced...

Hearing Loss Disease Treatment Market 2025: Government, Regulatory Support Drives Hearing Aids Market Growth

Hearing Loss Disease Treatment Market 2025: Government, Regulatory Support Drives Hearing Aids Market Growth

The Business Research Company's Hearing Loss Disease Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 17, 2025 /⁨EINPresswire.com⁩/ -- What Is The Growth...

Revieve and Simon Ourian M.D. Debut First-Ever AI Skincare and Nutrition Experience

Revieve and Simon Ourian M.D. Debut First-Ever AI Skincare and Nutrition Experience

LONDON, UNITED KINGDOM, June 17, 2025 /⁨EINPresswire.com⁩/ -- Revieve, a global leader in personalized digital brand experiences in beauty, skin, health and wellness, has partnered with Simon Ourian M.D. to launch the world’s first AI-powered...

Disposable Ostomy Bags Market: Discovering the Next Major Healthcare Innovation

Disposable Ostomy Bags Market: Discovering the Next Major Healthcare Innovation

Boston, June 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Disposable Ostomy Bags: Global Market” is projected to increase from $2.8 billion in 2024 to $3.7 billion by the end of 2031, at a compound annual...

Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity

Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity

Dapirolizumab pegol (DZP) showed efficacy across multiple clinical endpoints in the PHOENYCS GO study, including fatigue and measures of disease activity DZP showed consistent improvements in fatigue, a common and debilitating symptom of systemic...

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

US-based Dieter Weinand is the former CEO of Bayer Pharma with more than 25 years of experience as a senior business leader in the pharmaceutical industry The appointment comes as AstriVax Therapeutics matures as a clinical stage immunotherapy...

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 6 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid...

bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India

bonyf Welcomes Group Pharmaceuticals as Strategic Stakeholder to Drive Growth in India

bonyf is proud to announce that Group Pharmaceuticals (GP) has become a significant stakeholder in bonyf NV. GP has acquired a total of 13.5% of bonyf’s shares. bonyf NV (ENX:MLBON) KNOKKE-HEIST, KNOKKE-HEIST, BELGIUM, June 4, 2025...

 AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology

Third asset to advance into clinical trials, validating broad potential of Launch-iT platform All subjects treated with first dose of AVX70371 Launch-iT, as part of multiple dosing schedule Potential first-in-class treatment that could form part...

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 27, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...

Press release: Transparency Notification from Shareholders

Press release: Transparency Notification from Shareholders

Transparency Notification from Shareholders Ghent, Belgium – 26 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart...

Litigation Funding from a European Perspective

Litigation Funding from a European Perspective

In a recent report on litigation funding, Deminor CEO Erik Bomans examines key insights on how the litigation funding market has developed since 2023. BRUSSELS, BELGIUM, June 27, 2025 /⁨EINPresswire.com⁩/ -- International courts and media coverage...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service